stockmarketproxy
/
NBIXNasdaq SEC EDGAR

NEUROCRINE BIOSCIENCES INC

Biological Products, (No Diagnostic Substances)·SAN DIEGO, CA·FY end 12/31·CIK 914475
OverviewFinancialsCompensationGovernanceInsidersFilings

Named Executive Officers

FY 2025
ExecutiveSalaryStockOptionsBonus / Inc.OtherTotal
Sanjay KeswaniM.D.
$379.2K$4.0M$4.0M$488.0K$140.6K$9.0M
Jude OnyiaPh.D.
$638.3K$2.6M$3.4M$526.0K$58.8K$7.2M
Strategic Advisor
$686.8K$2.4M$3.2M$513.4K$64.1K$6.8M
Eric BenevichChief Commercial Officer
$636.8K$2.8M$2.4M$366.2K$53.1K$6.3M
Matthew C. AbernethyChief Financial Officer
$646.1K$1.8M$3.2M$355.3K$56.4K$6.1M
Kyle W. GanoPh.D.
$602.9K$1.8M$3.2M$331.6K$55.6K$6.0M
Eiry W. RobertsM.D.
$660.3K$2.1M$2.6M$399.5K$63.9K$5.9M
William H. Rastetter, Ph.D.
$400.0K$105.0K$505.0K
Shalini Sharp
$200.0K$200.0K$100.3K$500.3K
Stephen A. Sherwin, M.D.
$400.0K$93.3K$493.3K
Richard F. Pops
$400.0K$87.8K$487.8K
Christine A. Poon
$400.0K$83.8K$483.8K
George J. Morrow
$400.0K$81.0K$481.0K
Leslie V. Norwalk
$200.0K$200.0K$78.0K$478.0K
Kevin Gorman, Ph.D.
$400.0K$70.0K$470.0K
Gary A. Lyons
$200.0K$200.0K$70.0K$470.0K
Johanna Mercier
$400.0K$69.0K$469.0K

CEO comp · median worker · ratio — multi-year trend

Need at least two fiscal years of proxy data to draw the trend line. The ingestion worker will populate prior-year proxies as it processes them.